Association Between Age at Diagnosis and Risk of Major Adverse Cardiovascular Events in Patients With Hypertrophic Cardiomyopathy: A Single-Center Retrospective Cohort Study
This single-center retrospective study of 350 hypertrophic cardiomyopathy patients reveals that a younger age at diagnosis (≤50 years) is an independent predictor of increased major adverse cardiovascular events, primarily driven by new-onset atrial fibrillation, leading to the development of a nomogram that improves individualized risk stratification.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Heart muscle disease, known medically as hypertrophic cardiomyopathy, is a condition where the walls of the heart become unusually thick. This thickening makes it harder for the heart to pump blood efficiently and can disrupt the electrical signals that keep the heartbeat steady. While doctors have long been very good at predicting the risk of sudden cardiac arrest in these patients, they have had less success in forecasting other serious problems that develop over time, such as heart failure, heart attacks, or irregular heartbeats. These slower-moving complications are actually more common than sudden arrest and can significantly shorten a person's life or reduce their quality of life. Because the standard tools for assessing risk focus heavily on the danger of sudden death, doctors often lack a clear picture of who is most likely to suffer from these other long-term issues.
A team of researchers at the First Hospital of Jilin University in China decided to look for a simple clue that might help fill this gap. They turned their attention to the age at which a patient is first diagnosed with the disease. In many medical fields, the timing of a diagnosis can tell a lot about how a condition will behave, but this specific factor had not been thoroughly studied for predicting the broader range of heart problems in people with this muscle disease. The researchers wanted to see if being diagnosed younger or older made a difference in the likelihood of experiencing a major adverse cardiovascular event, a term they used to describe a serious combination of outcomes including sudden death, heart failure, heart attacks, or the new onset of an irregular heartbeat called atrial fibrillation.
To find the answer, the team looked back at the medical records of 350 patients who had been treated for this heart condition at their hospital between 2018 and 2026. They divided the group into two categories: those who were diagnosed at age 50 or younger, and those diagnosed after age 50. This cutoff was chosen because previous international studies suggested that 50 years is a meaningful boundary for distinguishing between early and late forms of the disease. The researchers then tracked these patients over time to see who developed the serious heart events they were studying. They carefully accounted for other factors that could influence the results, such as whether the patient had high blood pressure, diabetes, or existing damage to the heart muscle visible on special scans.
The results showed a clear pattern. Patients who were diagnosed at age 50 or younger faced a significantly higher risk of experiencing a major adverse cardiovascular event compared to those diagnosed later in life. Specifically, about 27 percent of the younger group experienced a serious event, while only about 16 percent of the older group did. When the researchers broke down the types of events, they found that the difference was driven mostly by the development of new irregular heartbeats, known as atrial fibrillation. The younger patients were much more likely to develop this condition than the older patients. While the risk of sudden death, heart attacks, or heart failure was also tracked, the data did not show a statistically significant difference between the two age groups for those specific outcomes on their own.
The study confirmed that being diagnosed at a younger age is an independent warning sign for a higher risk of these long-term complications, even after adjusting for other health factors like coronary artery disease or the severity of heart failure symptoms. The researchers also built a new prediction tool, which they called a nomogram, that combines the patient's age at diagnosis with other clinical details like heart wall thickness and the presence of scar tissue in the heart. This tool proved to be better at predicting who would have a major event than models that relied only on traditional clinical factors. The findings suggest that for patients diagnosed with this heart muscle disease before age 50, doctors should be particularly vigilant about monitoring for irregular heartbeats and other long-term risks, as these patients carry a heavier disease burden over their lifetime.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.